Hakutulokset - Moore, Kathleen N

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer Tekijä Moore, Kathleen N., Monk, Bradley J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations Tekijä Moore, Kathleen N., Birrer, Michael J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age? Tekijä Birrer, Michael J., Betella, Ilaria, Martin, Lainie P., Moore, Kathleen N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2 Tekijä Bishop, Erin A., Java, James J., Moore, Kathleen N., Walker, Joan L.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers Tekijä Kunos, Charles A., Andrews, Stephen J., Moore, Kathleen N., Chon, Hye Sook, Ivy, S. Percy

Hae kokoteksti Hae kokoteksti Hae kokoteksti

COST-EFFECTIVENESS OF NIRAPARIB, RUCAPARIB, AND OLAPARIB FOR TREATMENT OF PLATINUM-RESISTANT, RECURRENT OVARIAN CARCINOMA Tekijä WOLFORD, JULIET E., BAI, JIARU, MOORE, KATHLEEN N., KRISTELEIT, REBECCA, MONK, BRADLEY J., TEWARI, KRISHNANSU S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion Tekijä Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Suppressed expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma Tekijä Zakharov, Vladislav, Lin, Hsueh-Kung, Azzarello, Joseph, McMeekin, Scott, Moore, Kathleen N, Penning, Trevor M, Fung, Kar-Ming

Hae kokoteksti Hae kokoteksti

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders Tekijä Grisham, Rachel N., Moore, Kathleen N., Gordon, Michael S., Harb, Wael, Cody, Gwendolyn, Halpenny, Darragh F., Makker, Vicky, Aghajanian, Carol A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary... Tekijä Coward, Jermaine I., Barve, Minal A., Kichenadasse, Ganessan, Moore, Kathleen N., Harnett, Paul R., Berg, Daniel, Garner, James S., Dizon, Don S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours Tekijä Moore, Kathleen N, Bauer, Todd M, Falchook, Gerald S, Chowdhury, Swapan, Patel, Chirag, Neuwirth, Rachel, Enke, Aaron, Zohren, Fabian, Patel, Manish R

Hae kokoteksti Hae kokoteksti Hae kokoteksti

PROSPECTIVE EVALUATION OF MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER RISK INDEX SCORE FOR GYNECOLOGIC ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA Tekijä Gunderson, Camille C., Erickson, Britt. K., Wilkinson-Ryan, Ivy, Vesely, Sara K., Leath, Charles A., Gehrig, Paola A., Moore, Kathleen N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors Tekijä Bendell, Johanna C., Patel, Manish R., Moore, Kathleen N., Chua, Cynthia C., Arkenau, Hendrik‐Tobias, Dukart, Gary, Harrow, Kim, Liang, Chris

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A New Approach to Evaluate Drug Treatment Response of Ovarian Cancer Patients Based on Deformable Image Registration Tekijä Tan, Maxine, Li, Zheng, Qiu, Yuchen, McMeekin, Scott D., Thai, Theresa C., Ding, Kai, Moore, Kathleen N., Liu, Hong, Zheng, Bin

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors Tekijä Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors Tekijä Moore, Kathleen N., Bendell, Johanna C., LoRusso, Patricia M., Olszanski, Anthony J., Zwick-Wallasch, Esther, Jansen, Mendel, Vandell, Alexander G., Senaldi, Giorgio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A phase I–II evaluation of veliparib (NSC#737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: An NRG On... Tekijä Kunos, Charles, Deng, Wei, Dawson, Dawn, Lea, Jayanthi S., Zanotti, Kristine M., Gray, Heidi J., Bender, David P., Guaglianone, Perry P., Carter, Jori S., Moore, Kathleen N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer Tekijä Gordhandas, Sushmita B., Manning-Geist, Beryl, Henson, Christina, Iyer, Gopa, Gardner, Ginger J., Sonoda, Yukio, Moore, Kathleen N., Aghajanian, Carol, Chui, M. Herman, Grisham, Rachel N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Phase I Evaluation of Extended Field Radiation Therapy with Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women with Cervical Carcinom... Tekijä Boardman, Cecelia H, Brady, William E, Dizon, Don S, Kunos, Charles A, Moore, Kathleen N, Zanotti, Kristine M, Matthews, Cara, Cosin, Jonathan A, Aghajanian, Carol, Fracasso, Paula M

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Per... Tekijä Moore, Kathleen N., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula A., Konner, Jason A., Perez, Raymond P., Bauer, Todd M., Ruiz-Soto, Rodrigo, Birrer, Michael J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti